We focus on radical performance improvements that can be gained from all stages of the funding cycle, by continuously augmenting existing capabilities and workflows with GenAI. It's time to challenge 'old' assumptions about where funding is really necessary. Do you really need it, given the latent capability/capacity that the possibilities of augmenting your existing team with continuously improving generative AI? Will that merger or acquisition still be viable after the deal has been done? How can a funded project achieve 25% time, cost and quality improvements? As a Private Equity, Family Office or Venture Capital organisation, how is generative AI already impacting the performance of your portfolio? How can you leverage GenAI to realise your planned returns? These are powerful questions to ask.